: Inform on steps taken to import medicine for black fungus: Delhi HC to Centre #IndiaNEWS #Coronavirus New Delhi: The Delhi High Court Wednesday asked the Centre to take steps to get the medicine

Inform on steps taken to import medicine for black fungus: Delhi HC to Centre #IndiaNEWS #Coronavirus
New Delhi: The Delhi High Court Wednesday asked the Centre to take steps to get the medicine Amphotericin B used for treating black fungus which is primarily affecting Covid-19 recovered people, from wherever it is available in the world.
The court said that the Centre should inform it about steps taken to import medicine, the shortfall of which was coming in the way of treatment of Mucormycosis (black fungus) which has been on rise in the national capital and elsewhere in the country.
You have to get the medicine from wherever in the world. You have to take steps right now. Wherever it is available in the world get it, said a bench of Justices Vipin Sanghi and Jasmeet Singh which was assured by the Centre that it has already started taking steps to import the medicine.
The court noted that the domestic production of the medicine is far less than what is required in India and the Centre has informed that the production capacity of some of the producers has been doubled now. It, however, said, “looking at the shortfall in the supply, we are afraid that mere doubling of production will not suffice. It is not clear by when the augmented production will come in actual production. ???
The bench said, “The Centre may place on record the steps taken to import the medicine to augment the supplies within the country. ??? The bench said there are two things premium here, that is, time and human lives and if the supplies of the drug are not proper, it would be neither here nor there and it would not serve the purpose as the shortage is by two-third of the total demand.
“You need to import this to bridge the gap between your plan to enhance the capacity and completing manufacture before we lose more precious lives. So act fast on this,??? it said and asked the Central government to file a status on present production capacity of the medicine, details of producers licensed to produce it, and by when it would be manufactured with the increased capacity.
The court, which was told that currently Delhi has around 200 cases of Mucormycosis (black fungus), also asked the Centre to inform about the present case load and expected load in two weeks. The Centre has to file its report within three days. The issue of shortage of the medicine for treating black fungus was raised by advocate Rakesh Malhotra who said these cases are rising.
According to the Union Health Ministry, mucormycosis or black fungus is a complication caused by a fungal infection. People catch mucormycosis by coming in contact with the fungal spores in the environment. It can also develop on the skin after the fungus enters the skin through a cut, scrape, burn, or other type of skin trauma.

Stock Market NEWS Best intraday tips Intraday Stocks below 100